期刊文献+

血清糖化血红蛋白及脂蛋白-(a)水平变化与糖尿病并发冠心病的关系 被引量:3

Association of Serum Level of Hemoglobin A (1c) and lipoprotein-a with Coronary Artery Disease Complicating Diabetes Mellitus
下载PDF
导出
摘要 目的:探讨血清糖化血红蛋白(HbAlc)及脂蛋白-a[Lp(a)]水平变化与糖尿病并发冠心病的关系。方法:单纯2型糖尿病患者54例(糖尿病组)和2型糖尿病并发冠心病患者128例(糖尿病并发冠心病组),测定各组血清HbAlc和Lp(a)水平,通过Logistic回归和ROC曲线分析血清HbAlc和Lp(a)水平变化对糖尿病并发冠心病的相对危险性预测价值。结果:糖尿病合并冠心病组HbAlc(7.5±1.4)%和Lp(a)(0.25±0.19)g/L明显高于单纯糖尿病组[(6.9±1.4)%和(0.19±0.16)g/L,均P<0.05]。Logistic回归分析显示,血清高水平HbAlc和Lp(a)分别是糖尿病并发冠心病的独立危险因素(OR值2.28,95%CI1.12~4.63,P<0.05)及(OR值2.3,95%CI1.11~4.79,P<0.05)。Logistic回归模型的ROC曲线下面积为0.73(P<0.01)。最佳切点0.7对判断糖尿病患者并发冠心病的敏感性和特异性分别为70%和65%。结论:血清HbAlc和Lp-(a)水平是糖尿病患者并发冠心病的独立危险因素,对评估糖尿病并发冠心病的相对危险性具有临床价值。 Objective:To investigate the association of serum of hemoglobin A(1c)and Lipoprotein-a with coronary hear disease(CHD)in patients with type 2 diabetes mellitus.Method:Serum levels of hemoglobin A(1c)and Lipoprotein-a were measured in 54 with type 2 diabetes only and 128 patients with diabetes and CHD.Multivariate logistic regression analysis was performed to identify risk factors for CHD in diabetic patients.The predictive value of hemoglobin A(1c)and Lipoprotein-a for presence of CHD in diabetic patients was calculated by constructing receiver-operating characteristic curves(ROC).Results:Serum level of hemoglobin A(1c)(7.5±1.4)% and Lipoprotein-a(0.25±0.19)g/L in diabetic patients with CHD were significantly higher than those in patients with diabetes only(6.9±1.4)% and(0.19±0.16)g/L,P<0.05.Multivariate logistic regression analysis revealed that hemoglobin A(1c)and Lipoprotein-a were independent risk factors for CHD in diabetic patients(OR =2.28,95%CI 1.12~4.63,P<0.05)and(OR=2.3,95%CI 1.11~4.79,P<0.05).Area under the ROC curve for logistic regression model was 0.73,P<0.01.The optimal cut-off point for logistic regression model was 0.7(sensitivity 70%,specificity 65%)in the prediction of CHD in diabetic patients.Conclusion:Serum level of hemoglobin A(1c)and lipoprotein-a are independent risk factors for CHD in diabetic patients and may be useful in predicting the relative risk for CHD in patients with type 2 diabetes.
出处 《微循环学杂志》 2007年第3期39-41,共3页 Chinese Journal of Microcirculation
关键词 血管并发症 水平变化 糖尿病 冠心病 血清糖化 脂蛋白 晚期糖化终末产物 白及 Hemoglobin A(1c) Lipoprotein-a Diabetes Coronay heart disease
  • 相关文献

参考文献12

  • 1Basta G,Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Res, 2004,63(4):582-592.
  • 2Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vase Bio,2006,26 i5):1 156-1 162.
  • 3Aso Y,Inukai T,Tayama K,et al. Takemura Y. Serm concentration of anvanced glyeation end products are associated with the compent of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Aeta Diabetol, 2000,27 (2) : 87-92.
  • 4Stein JH, Rosenson RS. Lipoprotein (a) excess and coronary heart disease. Arch Intern Med,1997,157(11):1 161-1 162.
  • 5Diseepolo W, Wun T, Berglund L. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk. Pathophysiol Haemost Thromb, 2006, 35 (3-4) : 314 - 321.
  • 6Seanu AM, Lawn RM, Berg K. Lipoprotein(a) and atheroselerosis. Ann Intern Med,1991,115(3):209-218.
  • 7Fujino A,Watanabe T, Kunii H,et al. Lipoprotein(a) is a potential coronary risk factor. Jpn Circ J, 2000,64 (1): 51 -56.
  • 8Angles-Cano E, de la Pena Diaz A, Loyau S. Inhibition of fibrinolysis by lipoprotein(a). Ann N Y Acad Sci,2001,936:261- 275.
  • 9O'Brien T, Nguyen TT, Harrison JM, et al. Lipids and Lp (a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus. Mayo Clin Proc, 1994, 69(5):430-435.
  • 10Pedreno J, Fernandez R, Ballester A, et al. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease. Int J Cardiol,2000, 74 (2-3):169-170.

同被引文献26

  • 1陈慧丹,陈发林.HLC-723G7全自动糖化血红蛋白分析仪使用中的几个问题探讨[J].福建医药杂志,2006,28(1):113-114. 被引量:2
  • 2郑健彬,麦奇,黄伟英,何玉琴.糖尿病患者糖化血红蛋白和Lp(a)水平关系研究[J].河北医学,2006,12(4):298-300. 被引量:1
  • 3蒲里津,陆林,沈卫峰.晚期糖基化终末产物致动脉粥样硬化的机制[J].国际心血管病杂志,2006,33(2):98-100. 被引量:9
  • 4Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med, 2001,344(6) : 431-442.
  • 5Vasan RS,Evans JC,Benjamin EJ, et al. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham heart study. Hypertension,2004,43(5):957-962.
  • 6Johansson M, Elam M, Rundqvist B, et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation, 1999, 99(19): 2 537-2 542.
  • 7Pimenta E, Gaddam KK, Oparil S. Mechanisms and treatment of resistant hypertension. J Clin Hypertens, 2008,10(3) : 239-244.
  • 8Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors inpatients undergoing routine cardiac catheterization. J Am Soc Nephrol, 1992, 2 (11): 1 608-1 616.
  • 9Van Helvoort-Postulart D, Dirksen CD, Nelemans PJ,et al. Renal artery stenosis: cost-effectiveness ofdiagnosis and treatment. Radiology, 2007,244 (2) : 505-513.
  • 10Amoroso G, Laarman GJ, Kiemeneij F. Overview of the transradial approach in percutaneous coronary intervention. J Cardiovasc Med, 2007,8(4) :230-237.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部